Oral Anticancer Heterobimetallic PtIV -AuI Complexes Show High In Vivo Activity and Low Toxicity.
Babu T, Ghareeb H, Basu U, Schueffl H, Theiner S, Heffeter P, Koellensperger G, Metanis N, Gandin V, Ott I, Schmidt C, Gibson D.
Babu T, et al. Among authors: theiner s.
Angew Chem Int Ed Engl. 2023 Mar 1;62(10):e202217233. doi: 10.1002/anie.202217233. Epub 2023 Jan 31.
Angew Chem Int Ed Engl. 2023.
PMID: 36628505